Role of IL-33-ST2 pathway in regulating inflammation: current evidence and future perspectives
Abstract Interleukin (IL)-33 is an alarmin of the IL-1 superfamily localized to the nucleus of expressing cells, such as endothelial cells, epithelial cells, and fibroblasts. In response to cellular damage or stress, IL-33 is released and activates innate immune responses in some immune and structur...
Main Authors: | Yilu Zhou, Zhendong Xu, Zhiqiang Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-12-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-023-04782-4 |
Similar Items
-
The production, function, and clinical applications of IL-33 in type 2 inflammation-related respiratory diseases
by: Shiyao Gu, et al.
Published: (2024-09-01) -
Association of IL‐33 in modeling type‐2 airway inflammation and pulmonary emphysema in mice
by: Chika Miyaoka, et al.
Published: (2024-04-01) -
The Relationship between the Genetic Polymorphisms of Interleukin-33 (IL-33) and Interleukin-1 Receptor-Like 1 (IL1R1) with the Levels of Interleukin-33 in Patients with Asthma and Multiple Sclerosis
by: Maryam Ahmadi, et al.
Published: (2016-02-01) -
IL-33 in Mental Disorders
by: Gianluca Pandolfo, et al.
Published: (2021-03-01) -
The ST2/IL-33 Pathway in Adult and Paediatric Heart Disease and Transplantation
by: Giacomina Brunetti, et al.
Published: (2023-06-01)